{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:53:18Z","timestamp":1790142798319,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Gilead Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10817-6","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:37:01Z","timestamp":1744418221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Remdesivir associated with reduced mortality in hospitalized COVID-19 patients: treatment effectiveness using real-world data and natural language processing"],"prefix":"10.1186","volume":"25","author":[{"given":"Jos\u00e9 Ram\u00f3n","family":"Arribas L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Pilar","family":"Ruiz Seco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Fanjul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"D\u00edaz Poll\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Gonz\u00e1lez Ruano P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Ferre Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"De Miguel Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Portillo Horcajada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"De \u00c1lvaro P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Jorge","family":"Barroso Santos Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Savana Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Luis","family":"Valdivieso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Fanjul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Sarr\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Cabal-Hierro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Menke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Casadevall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Mar\u00edn-Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miren","family":"Taberna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melchor","family":"Riera Jaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"key":"10817_CR1","unstructured":"WHO Coronavirus (COVID-19) dashboard. https:\/\/covid19.who.int\/."},{"issue":"19","key":"10817_CR2","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1056\/NEJMe2005477","volume":"382","author":"LR Baden","year":"2020","unstructured":"Baden LR, Rubin EJ. Covid-19 - the search for effective therapy. N Engl J Med. 2020;382(19):1851\u20132.","journal-title":"N Engl J Med"},{"issue":"159","key":"10817_CR3","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0384-2020","volume":"30","author":"T Welte","year":"2021","unstructured":"Welte T, Ambrose LJ, Sibbring GC, Sheikh S, Mullerova H, Sabir I. Current evidence for COVID-19 therapies: a systematic literature review. Eur Respir Rev. 2021;30(159): 200384.","journal-title":"Eur Respir Rev"},{"issue":"3","key":"10817_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269\u201371.","journal-title":"Cell Res"},{"issue":"12","key":"10817_CR5","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1073\/pnas.1922083117","volume":"117","author":"E de Wit","year":"2020","unstructured":"de Wit E, Feldmann F, Cronin J, Jordan R, Okumura A, Thomas T, Scott D, Cihlar T, Feldmann H. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc Natl Acad Sci U S A. 2020;117(12):6771\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"41","key":"10817_CR6","doi-asserted-by":"publisher","first-page":"16598","DOI":"10.1073\/pnas.1310744110","volume":"110","author":"E de Wit","year":"2013","unstructured":"de Wit E, Rasmussen AL, Falzarano D, Bushmaker T, Feldmann F, Brining DL, Fischer ER, Martellaro C, Okumura A, Chang J, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci U S A. 2013;110(41):16598\u2013603.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"10817_CR7","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, et al. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020;383(19):1813\u201326.","journal-title":"N Engl J Med"},{"issue":"27","key":"10817_CR8","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1056\/NEJMp2032369","volume":"383","author":"D Rubin","year":"2020","unstructured":"Rubin D, Chan-Tack K, Farley J, Sherwat A. FDA approval of remdesivir - a step in the right direction. N Engl J Med. 2020;383(27):2598\u2013600.","journal-title":"N Engl J Med"},{"key":"10817_CR9","unstructured":"First COVID-19 treatment recommended for EU authorisation. https:\/\/www.ema.europa.eu\/en\/documents\/press-release\/first-covid-19-treatment-recommended-eu-authorisation_en.pdf."},{"issue":"1","key":"10817_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/s13063-021-05489-x","volume":"22","author":"EH Weissler","year":"2021","unstructured":"Weissler EH, Naumann T, Andersson T, Ranganath R, Elemento O, Luo Y, Freitag DF, Benoit J, Hughes MC, Khan F, et al. The role of machine learning in clinical research: transforming the future of evidence generation. Trials. 2021;22(1):537.","journal-title":"Trials"},{"issue":"3","key":"10817_CR11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1136\/ard-2022-222626","volume":"82","author":"R Knevel","year":"2023","unstructured":"Knevel R, Liao KP. From real-world electronic health record data to real-world results using artificial intelligence. Ann Rheum Dis. 2023;82(3):306\u201311.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10817_CR12","first-page":"25","volume":"37","author":"A Dang","year":"2023","unstructured":"Dang A. Real-World Evidence: A Primer. Pharmaceut Med. 2023;37(1):25\u201336.","journal-title":"Pharmaceut Med"},{"issue":"1","key":"10817_CR13","first-page":"1123","volume":"5","author":"S Lee","year":"2020","unstructured":"Lee S, Xu Y, D\u2019Souza A, Martin EA, Doktorchik C, Zhang Z, Quan H. Unlocking the potential of electronic health records for health research. Int J Popul Data Sci. 2020;5(1):1123.","journal-title":"Int J Popul Data Sci"},{"issue":"4","key":"10817_CR14","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s43441-021-00288-7","volume":"55","author":"S Khosla","year":"2021","unstructured":"Khosla S, Tepie MF, Nagy MJ, Kafatos G, Seewald M, Marchese S, Liwing J. The alignment of real-world evidence and digital health: realising the opportunity. Ther Innov Regul Sci. 2021;55(4):889\u201398.","journal-title":"Ther Innov Regul Sci"},{"issue":"2","key":"10817_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.arbres.2019.12.025","volume":"57","author":"JL Izquierdo","year":"2021","unstructured":"Izquierdo JL, Morena D, Gonz\u00e1lez Y, Paredero JM, P\u00e9rez B, Graziani D, Guti\u00e9rrez M, Rodr\u00edguez JM. Clinical management of COPD in a real-world setting. A big data analysis. Arch Bronconeumol. 2021;57(2):94\u2013100.","journal-title":"Arch Bronconeumol"},{"issue":"7","key":"10817_CR16","doi-asserted-by":"publisher","first-page":"e20492","DOI":"10.2196\/20492","volume":"9","author":"L Canales","year":"2021","unstructured":"Canales L, Menke S, Marchesseau S, D\u2019Agostino A, Del Rio-Bermudez C, Taberna M, Tello J. Assessing the Performance of Clinical Natural Language Processing Systems: Development of an Evaluation Methodology. JMIR Med Inform. 2021;9(7):e20492.","journal-title":"JMIR Med Inform"},{"issue":"10","key":"10817_CR17","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/s41592-024-02405-4","volume":"21","author":"CF Kurz","year":"2024","unstructured":"Kurz CF, Krzywinski M, Altman N. Propensity score matching. Nat Methods. 2024;21(10):1770\u20132.","journal-title":"Nat Methods"},{"issue":"2","key":"10817_CR18","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.arthro.2021.06.037","volume":"38","author":"JW Chen","year":"2022","unstructured":"Chen JW, Maldonado DR, Kowalski BL, Miecznikowski KB, Kyin C, Gornbein JA, Domb BG. Best practice guidelines for propensity score methods in medical research: consideration on theory, implementation, and reporting. A review. Arthroscopy. 2022;38(2):632\u201342.","journal-title":"Arthroscopy"},{"issue":"3","key":"10817_CR19","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1213\/ANE.0000000000003653","volume":"127","author":"P Schober","year":"2018","unstructured":"Schober P, Vetter TR. Survival analysis and interpretation of time-to-event data: the tortoise and the hare. Anesth Analg. 2018;127(3):792\u20138.","journal-title":"Anesth Analg"},{"issue":"5","key":"10817_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1080\/10543406.2017.1405012","volume":"28","author":"SH Jung","year":"2018","unstructured":"Jung SH, Lee HY, Chow SC. Statistical Methods for Conditional Survival Analysis. J Biopharm Stat. 2018;28(5):927\u201338.","journal-title":"J Biopharm Stat"},{"key":"10817_CR21","doi-asserted-by":"publisher","first-page":"2290120","DOI":"10.1155\/2021\/2290120","volume":"2021","author":"G D'Arrigo","year":"2021","unstructured":"D\u2019Arrigo G, Leonardis D, Abd ElHafeez S, Fusaro M, Tripepi G, Roumeliotis S. Methods to analyse time-to-event data: the kaplan-meier survival curve. Oxid Med Cell Longev. 2021;2021:2290120.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"10817_CR22","doi-asserted-by":"publisher","first-page":"471","DOI":"10.21873\/anticanres.16835","volume":"44","author":"G Beis","year":"2024","unstructured":"Beis G, Iliopoulos A, Papasotiriou I. An overview of introductory and advanced survival analysis methods in clinical applications: where have we come so far? Anticancer Res. 2024;44(2):471\u201387.","journal-title":"Anticancer Res"},{"issue":"4","key":"10817_CR23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/risa.12865","volume":"38","author":"SH Moolgavkar","year":"2018","unstructured":"Moolgavkar SH, Chang ET, Watson HN, Lau EC. An assessment of the cox proportional hazards regression model for epidemiologic studies. Risk Anal. 2018;38(4):777\u201394.","journal-title":"Risk Anal"},{"issue":"10339","key":"10817_CR24","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(22)00519-0","volume":"399","author":"WHO Solidarity Trial Consortium","year":"2022","unstructured":"WHO Solidarity Trial Consortium. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses. Lancet (London, England). 2022;399(10339):1941\u201353.","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10817_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S2213-2600(22)00528-8","volume":"11","author":"A Amstutz","year":"2023","unstructured":"Amstutz A, Speich B, Mentre F, Rueegg CS, Belhadi D, Assoumou L, Burdet C, Murthy S, Dodd LE, Wang Y, et al. Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials. Lancet Respir Med. 2023;11(5):453\u201364.","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10817_CR26","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1093\/cid\/ciab698","volume":"74","author":"GA Diaz","year":"2022","unstructured":"Diaz GA, Christensen AB, Pusch T, Goulet D, Chang SC, Grunkemeier GL, McKelvey PA, Robicsek A, French T, Parsons GT, et al. Remdesivir and mortality in patients with coronavirus disease 2019. Clin Infect Dis. 2022;74(10):1812\u201320.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10817_CR27","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1093\/cid\/ciab875","volume":"75","author":"E Mozaffari","year":"2022","unstructured":"Mozaffari E, Chandak A, Zhang Z, Liang S, Thrun M, Gottlieb RL, Kuritzkes DR, Sax PE, Wohl DA, Casciano R, et al. Remdesivir treatment in hospitalized patients with coronavirus disease 2019 (COVID-19): a comparative analysis of in-hospital all-cause mortality in a large multicenter observational cohort. Clin Infect Dis. 2022;75(1):e450\u20138.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10817_CR28","doi-asserted-by":"publisher","first-page":"ofab278","DOI":"10.1093\/ofid\/ofab278","volume":"8","author":"SA Olender","year":"2021","unstructured":"Olender SA, Walunas TL, Martinez E, Perez KK, Castagna A, Wang S, Kurbegov D, Goyal P, Ripamonti D, Balani B, et al. Remdesivir versus standard-of-care for severe coronavirus disease 2019 infection: an analysis of 28-day mortality. Open Forum Infect Diseases. 2021;8(7):ofab278.","journal-title":"Open Forum Infect Diseases"},{"issue":"12","key":"10817_CR29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.44505","volume":"5","author":"AP Chokkalingam","year":"2022","unstructured":"Chokkalingam AP, Hayden J, Goldman JD, Li H, Asubonteng J, Mozaffari E, Bush C, Wang JR, Kong A, Osinusi AO, et al. Association of Remdesivir Treatment With Mortality Among Hospitalized Adults With COVID-19 in the United States. JAMA Netw Open. 2022;5(12): e2244505.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10817_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s41669-020-00243-6","volume":"5","author":"MR Anderson","year":"2021","unstructured":"Anderson MR, Bach PB, Baldwin MR. Hospital length of stay for patients with severe COVID-19: implications for remdesivir\u2019s value. PharmacoEconomics-open. 2021;5(1):129\u201331.","journal-title":"PharmacoEconomics-open"},{"issue":"7","key":"10817_CR31","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.14741","volume":"4","author":"ME Ohl","year":"2021","unstructured":"Ohl ME, Miller DR, Lund BC, Kobayashi T, Richardson Miell K, Beck BF, Alexander B, Crothers K, Vaughan Sarrazin MS. Association of remdesivir treatment with survival and length of hospital stay among US veterans hospitalized with COVID-19. JAMA Netw Open. 2021;4(7): e2114741.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10817_CR32","doi-asserted-by":"publisher","first-page":"e003353","DOI":"10.1136\/rmdopen-2023-003353","volume":"10","author":"JA Roman Ivorra","year":"2024","unstructured":"Roman Ivorra JA, Trallero-Araguas E, Lopez Lasanta M, Cebrian L, Lojo L, Lopez-Muniz B, Fernandez-Melon J, Nunez B, Silva-Fernandez L, Veiga Cabello R, et al. Prevalence and clinical characteristics of patients with rheumatoid arthritis with interstitial lung disease using unstructured healthcare data and machine learning. RMD Open. 2024;10(1):e003353.","journal-title":"RMD Open"},{"key":"10817_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.thromres.2023.06.015","volume":"228","author":"AJ Munoz","year":"2023","unstructured":"Munoz AJ, Souto JC, Lecumberri R, Obispo B, Sanchez A, Aparicio J, Aguayo C, Gutierrez D, Palomo AG, Fanjul V, et al. Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning. Thromb Res. 2023;228:181\u20138.","journal-title":"Thromb Res"},{"issue":"2","key":"10817_CR34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.33588\/rn.7802.2023120","volume":"78","author":"MI Morales-Casado","year":"2024","unstructured":"Morales-Casado MI, Diezma-Martin AM, Munoz-Escudero F, Ronsenstone-Calvo S, Mondejar-Marin B, Vadillo-Bermejo A, Marsal-Alonso C, Beneyto-Martin P. Association between myasthenia gravis and Alzheimer\u2019s disease. Rev Neurol. 2024;78(2):41\u20136.","journal-title":"Rev Neurol"},{"issue":"2","key":"10817_CR35","doi-asserted-by":"publisher","first-page":"e004302","DOI":"10.1136\/rmdopen-2024-004302","volume":"10","author":"D Benavent","year":"2024","unstructured":"Benavent D, Benavent-Nunez M, Marin-Corral J, Arias-Manjon J, Navarro-Compan V, Taberna M, Salcedo I, Peiteado D, Carmona L, de Miguel E, et al. Natural language processing to identify and characterize spondyloarthritis in clinical practice. RMD Open. 2024;10(2):e004302.","journal-title":"RMD Open"},{"issue":"4","key":"10817_CR36","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/cpt.3161","volume":"115","author":"JC Hsu","year":"2024","unstructured":"Hsu JC, Wu M, Kim C, Vora B, Lien YTK, Jindal A, Yoshida K, Kawakatsu S, Gore J, Jin JY, et al. Applications of advanced natural language processing for clinical pharmacology. Clin Pharmacol Ther. 2024;115(4):786\u201394.","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"10817_CR37","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1109\/JBHI.2020.2977925","volume":"24","author":"HC Tissot","year":"2020","unstructured":"Tissot HC, Shah AD, Brealey D, Harris S, Agbakoba R, Folarin A, Romao L, Roguski L, Dobson R, Asselbergs FW. Natural language processing for mimicking clinical trial recruitment in critical care: a semi-automated simulation based on the LeoPARDS trial. IEEE J Biomed Health Inform. 2020;24(10):2950\u20139.","journal-title":"IEEE J Biomed Health Inform"},{"key":"10817_CR38","first-page":"126","volume":"2014","author":"J Zeng","year":"2014","unstructured":"Zeng J, Wu Y, Bailey A, Johnson A, Holla V, Bernstam EV, Xu H, Meric-Bernstam F. Adapting a natural language processing tool to facilitate clinical trial curation for personalized cancer therapy. AMIA Jt Summits Transl Sci Proc. 2014;2014:126\u201331.","journal-title":"AMIA Jt Summits Transl Sci Proc"},{"issue":"3","key":"10817_CR39","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s43441-024-00627-4","volume":"58","author":"KH Zou","year":"2024","unstructured":"Zou KH, Vigna C, Talwai A, Jain R, Galaznik A, Berger ML, Li JZ. The next horizon of drug development: external control arms and innovative tools to enrich clinical trial data. Ther Innov Regul Sci. 2024;58(3):443\u201355.","journal-title":"Ther Innov Regul Sci"},{"issue":"1","key":"10817_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41746-022-00590-0","volume":"5","author":"S Khurshid","year":"2022","unstructured":"Khurshid S, Reeder C, Harrington LX, Singh P, Sarma G, Friedman SF, Di Achille P, Diamant N, Cunningham JW, Turner AC, et al. Cohort design and natural language processing to reduce bias in electronic health records research. NPJ Digit Med. 2022;5(1):47.","journal-title":"NPJ Digit Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10817-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10817-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10817-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T21:19:27Z","timestamp":1744492767000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10817-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10817"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10817-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,12]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was classified as a \u2018non-interventional post-authorization study\u2019 by the Spanish Agency of Medicines and Health Products and was reviewed and approved by the Drug Research Ethics Committee of the Balearic Islands (IB 4731\/21 EOm) as the reference Ethics Committee. All methods and analysis followed legal and regulatory requirements and generally accepted research practices described in the latest edition of the Declaration of Helsinki, Good Pharmacoepidemiology Practices, and applicable local regulations. Informed consent was waived by the Drug Research Ethics Committee of the Balearic Islands, as data were retrospectively analyzed from patient EHRs, anonymized, and aggregated in an irreversibly dissociated manner. Data collection and assessment were obtained as part of routine clinical activity and performed in a blinded manner.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JRA reports personal fees from Viiv, Janssen, Gilead, MSD, and Aelix outside the submitted work. MPRS, LPH received personal fees from Gilead for patient review. RDMB reports personal fees (speaker fee and congress attendance grants) from Viiv, and Gilead. CDAP and PJBSC are employees of Gilead Sciences. FFL, BDP, PGRP, AFB, and MRJ declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"513"}}